News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Brien Anthony Stephen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2020 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.06, valued at
$253k
|
|
| 06/06/2019 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $6.05, valued at
$302.5k
|
|
| 07/27/2018 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 12,875 options to buy
@ $2.31, valued at
$29.7k
|
|
| 03/14/2018 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 24,691 options to buy
@ $7.29, valued at
$180k
|
|
|
|